439

Compound name
Brigatinib
Alt Name
ALUNBRIG
AP-26113
Compound Image
Brigatinib.png
SMILES
CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC
MW
584.10
Brutto
C29H39ClN7O2P
InChI
InChI=1S/C29H39ClN7O2P/c1-35-15-17-37(18-16-35)21-11-13-36(14-12-21)22-9-10-24(26(19-22)39-2)33-29-31-20-23(30)28(34-29)32-25-7-5-6-8-27(25)40(3,4)38/h5-10,19-21H,11-18H2,1-4H3,(H2,31,32,33,34)
InChI Key
AILRADAXUVEEIR-UHFFFAOYSA-N
Approval Jurisdiction
2017 FDA 2018 EMA
Approved for clinical use
ALK-Rearranged Metastatic NSCLC
CAS
1197953-54-0
PubChem CID
68165256
Action
ALK; T790M; EGFR
Approved Drug List
1
Commercial Vendor
Ariad Pharmaceuticals